$25.780
-0.394 (-1.53%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
AKTS 相似圖表分析預測
Alphio's AKTS stock price prediction model matches the current Aktis Oncology Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $25.81 (+0.10%). The 1-week path is $26.11 (+1.29%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Aktis Oncology Inc 股票嗎？
Aktis Oncology (AKTS) is a good buy right now due to its current price of $25.78, which is significantly lower than the analyst price target of $40 set by Raymond James, indicating a potential upside of 55%. Additionally, the stock has shown a positive momentum with a 5-day change of +7.10% and a 20-day change of +16.81%. The main risk is the negative net income reported at -24,144,000 USD for Q2 2026, which reflects ongoing financial challenges.
AKTS 股價於 Friday 收在 $25.78，此前下跌 -1.53%
Aktis Oncology Inc (AKTS) last closed at $25.78, losing -1.53%. These facts feed the 1-day and 1-week AKTS price prediction above.
分析師一致預期
Aktis Oncology Inc（AKTS）：買進 3、持有 0、賣出 0。展望：Strong Buy。
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
預測驅動因素
Aktis Oncology Inc（AKTS）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
相似圖表形態
近期走勢與 AKTS 最接近的股票，依相似度排序。
AKTS 季節性分析
Historically the probability of a positive August return for AKTS is 45.24%. July offers the highest probability of a positive month at 45.45%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。